drugset / Trial / NCT05997355

Preoperative Gabapentin for Cosmetic Breast Surgery

NCT05997355

Unknown 100 enrolled University of Puerto Rico
RandomizedSingle-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to compare postoperative pain and opioid consumption in patients who undergo cosmetic breast surgery and are treated preoperatively with gabapentin. The main questions to answer are the amount of postoperative pain on a scale of 0-10 and amount of opioids consumed postoperatively. Participants will be randomized into two groups: treatment vs no treatment. Treatment group will receive 600mg of gabapentin preopreatively. Researchers will compare treatment vs no treatment group to determine the effects of preoperative gabapentin on postoperative pain management and opioid consumption.

Timeline

Start
2023-09-01
Primary completion
2024-07-31
Completion
2024-07-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 600 mg

Indications

No indication recorded.